You have 9 free searches left this month | for more free features.

recurrent childhood anaplastic astrocytoma

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Childhood Astrocytoma, Childhood Atypical Teratoid/Rhabdoid Tumor, Diffuse Intrinsic Pontine Glioma Trial in Rochester

Active, not recruiting
  • Childhood Astrocytoma
  • +9 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Sep 8, 2022

Childhood Choroid Plexus Tumor, Childhood Ependymoblastoma, Childhood Grade III Meningioma Trial in United States (palbociclib

Terminated
  • Childhood Choroid Plexus Tumor
  • +18 more
  • palbociclib isethionate
  • +2 more
  • Los Angeles, California
  • +10 more
Feb 10, 2021

Astrocytoma, Glioblastoma Trial in Spain, United States (CC-90010)

Active, not recruiting
  • Astrocytoma
  • Glioblastoma
  • Jacksonville, Florida
  • +8 more
Dec 14, 2022

Glioblastoma Multiforme, Anaplastic Astrocytoma, Gliosarcoma Trial in Birmingham (M032, Pembrolizumab)

Recruiting
  • Glioblastoma Multiforme
  • +2 more
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jan 30, 2023

IDH Family Wildtype, Recurrent Anaplastic Astrocytoma, Recurrent Glioblastoma Trial in Houston (Laser Interstitial Thermal

Terminated
  • IDH Family Wildtype
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 14, 2022

Recurrent High Grade Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial (PCI 24781, Temozolomide)

Not yet recruiting
  • Recurrent High Grade Glioma
  • +4 more
  • (no location specified)
Jan 24, 2023

Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte

Withdrawn
  • Recurrent Anaplastic Astrocytoma
  • +7 more
  • Neural Stem Cells-expressing CRAd-S-pk7
  • Resection
  • (no location specified)
Nov 22, 2022

Recurrent High-grade Glioma, Recurrent Glioblastoma, Recurrent Anaplastic Astrocytoma Trial in Incheon (500mg/kg/3hr followed by

Recruiting
  • Recurrent High-grade Glioma
  • +3 more
  • 500mg/kg/3hr followed by neutron irradiation to reach maximum brain dose of 9Gy-Eq
  • +2 more
  • Incheon, Korea, Republic of
    Gachon University Gil Medical Center
Feb 19, 2023

Glioblastoma, Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma Trial in New York (Intra-arterial Cetuximab, Intra-arterial

Recruiting
  • Glioblastoma
  • +8 more
  • Intra-arterial Cetuximab
  • +2 more
  • New York, New York
    Lenox Hill Brain Tumor Center
Oct 17, 2022

Glioblastoma Multiforme of Brain, Anaplastic Astrocytoma of Brain, Gliosarcoma of Brain Trial in Birmingham (C134)

Active, not recruiting
  • Glioblastoma Multiforme of Brain
  • +2 more
  • C134
  • Birmingham, Alabama
    University of Alabama at Birmingham
Sep 19, 2022

Brain Tumor, Recurrent, Glioblastoma, Anaplastic Astrocytoma Trial in New York (Cytoreductive surgery, Perifosine, Temsirolimus)

Active, not recruiting
  • Brain Tumor, Recurrent
  • +4 more
  • Cytoreductive surgery
  • +2 more
  • New York, New York
  • +1 more
Jun 9, 2022

Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte

Active, not recruiting
  • Recurrent Anaplastic Astrocytoma
  • +6 more
  • Carboxylesterase-expressing Allogeneic Neural Stem Cells
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Jun 7, 2022

Recurrent Glioblastoma Multiforme, Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma or Gliosarcoma Trial in

Active, not recruiting
  • Recurrent Glioblastoma Multiforme
  • +2 more
  • M032 (NSC 733972)
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jan 26, 2022

Tumors, High Grade Glioma, Glioblastoma Multiforme Trial in Birmingham (Biological G207)

Not yet recruiting
  • Neoplasms
  • +7 more
  • Biological G207
  • Birmingham, Alabama
    Children's of Alabama
Jun 1, 2022

Glioblastoma Multiforme, Anaplastic Astrocytoma, Malignant Brain Tumor Trial in Indianapolis (Cabozantinib)

Terminated
  • Glioblastoma Multiforme
  • +3 more
  • Indianapolis, Indiana
    Riley Hospital for Children at IU Health
Jul 21, 2022

Glioma, Malignant, High Grade Glioma, Glioblastoma Trial in Tampa (OS2966, Gadoteridol)

Active, not recruiting
  • Glioma, Malignant
  • +4 more
  • Tampa, Florida
    Moffitt Cancer Center
Nov 28, 2022

CNS Tumors, Glioblastoma, Gliosarcoma, Adult Trial run by the (ONC206)

Recruiting
  • Central Nervous System Neoplasms
  • +22 more
  • Bethesda, Maryland
    National Institutes of Health
Mar 1, 2022

Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in United States (INCB7839)

Recruiting
  • Glioblastoma Multiforme
  • +5 more
  • Los Angeles, California
  • +12 more
Jan 9, 2023

Brain Tumor, Astrocytoma, Astroglioma Trial run by the NCI (Zotiraciclib (TG02), Temozolomide (TMZ))

Completed
  • Brain Tumor
  • +4 more
  • Zotiraciclib (TG02)
  • Temozolomide (TMZ)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Sep 3, 2021

Supratentorial Tumors, Malignant, Malignant Glioma, Glioblastoma Trial in Birmingham, Columbus (G207)

Active, not recruiting
  • Supratentorial Neoplasms, Malignant
  • +6 more
  • G207
  • Birmingham, Alabama
  • +1 more
Jun 1, 2022

Anaplastic Astrocytoma, Anaplastic Ependymoma, Anaplastic Oligodendroglioma Trial in United States (other, drug, procedure)

Active, not recruiting
  • Anaplastic Astrocytoma
  • +6 more
  • Laboratory Biomarker Analysis
  • +4 more
  • Los Angeles, California
  • +11 more
Jul 1, 2022

Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma Trial in Duarte (biological,

Completed
  • Adult Anaplastic Astrocytoma
  • +6 more
  • E. coli CD-expressing genetically modified neural stem cells
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Sep 28, 2021

Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Diffuse Astrocytoma Trial in New York (other, drug,

Completed
  • Adult Anaplastic Astrocytoma
  • +8 more
  • Laboratory Biomarker Analysis
  • +3 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jun 28, 2021

Anaplastic Astrocytoma, Recurrent Anaplastic Astrocytoma Trial in Worldwide (Eflornithine, Lomustine)

Active, not recruiting
  • Anaplastic Astrocytoma
  • Recurrent Anaplastic Astrocytoma
  • Birmingham, Alabama
  • +78 more
Jan 19, 2022